- Home
- AMPH vs ARR Comparison
AMPH vs ARR Comparison
Compare AMPH & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- ARR
- Stock Information
- Founded
- AMPH 1996
- ARR 2008
- Country
- AMPH United States
- ARR United States
- Employees
- AMPH N/A
- ARR N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- ARR Real Estate Investment Trusts
- Sector
- AMPH Health Care
- ARR Real Estate
- Exchange
- AMPH Nasdaq
- ARR Nasdaq
- Market Cap
- AMPH 1.3B
- ARR 1.4B
- IPO Year
- AMPH 2014
- ARR N/A
- Fundamental
- Price
- AMPH $28.29
- ARR $17.04
- Analyst Decision
- AMPH Hold
- ARR Hold
- Analyst Count
- AMPH 3
- ARR 3
- Target Price
- AMPH $43.50
- ARR $21.00
- AVG Volume (30 Days)
- AMPH 569.1K
- ARR 3.0M
- Earning Date
- AMPH 05-07-2025
- ARR 04-24-2025
- Dividend Yield
- AMPH N/A
- ARR 16.91%
- EPS Growth
- AMPH 17.69
- ARR N/A
- EPS
- AMPH 3.06
- ARR N/A
- Revenue
- AMPH $731,967,000.00
- ARR $39,256,000.00
- Revenue This Year
- AMPH $2.60
- ARR $543.67
- Revenue Next Year
- AMPH $9.42
- ARR $27.70
- P/E Ratio
- AMPH $9.25
- ARR N/A
- Revenue Growth
- AMPH 13.59
- ARR N/A
- 52 Week Low
- AMPH $25.89
- ARR $16.71
- 52 Week High
- AMPH $53.96
- ARR $21.93
- Technical
- Relative Strength Index (RSI)
- AMPH 43.50
- ARR 22.47
- Support Level
- AMPH $28.01
- ARR $16.71
- Resistance Level
- AMPH $29.18
- ARR $18.75
- Average True Range (ATR)
- AMPH 0.79
- ARR 0.35
- MACD
- AMPH 0.35
- ARR -0.18
- Stochastic Oscillator
- AMPH 72.95
- ARR 15.07
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.